Detalles de la búsqueda
1.
Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.
Neurochem Res
; 48(10): 3027-3041, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37289348
2.
Correction to: Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.
Neurochem Res
; 48(11): 3472, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37440119
3.
Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.
Int J Neuropsychopharmacol
; 18(2)2014 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-25552430
4.
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.
J Psychopharmacol
; 36(3): 258-272, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35107059
5.
The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia.
J Pharmacol Exp Ther
; 338(1): 100-13, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21487071
6.
Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia.
J Mol Neurosci
; 38(3): 227-35, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19455435
7.
Nicotinic α7 and α4ß2 agonists enhance the formation and retrieval of recognition memory: Potential mechanisms for cognitive performance enhancement in neurological and psychiatric disorders.
Behav Brain Res
; 302: 73-80, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26327238
8.
Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology.
Eur Neuropsychopharmacol
; 26(1): 3-14, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26655189
9.
A systematic review and meta-analysis of cognitive remediation in early schizophrenia.
Schizophr Res
; 168(1-2): 213-22, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26305063
10.
The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania.
Expert Opin Drug Discov
; 8(1): 93-103, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23121334
11.
First episode psychosis patients show impaired cognitive function--a study of a South Asian population in the UK.
J Psychopharmacol
; 27(4): 366-73, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23427189
12.
D1 receptor activation improves vigilance in rats as measured by the 5-choice continuous performance test.
Psychopharmacology (Berl)
; 220(1): 129-41, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21901319
13.
Rats tested after a washout period from sub-chronic PCP administration exhibited impaired performance in the 5-Choice Continuous Performance Test (5C-CPT) when the attentional load was increased.
Neuropharmacology
; 62(3): 1432-41, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21569782
14.
PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats.
J Psychopharmacol
; 26(9): 1265-70, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22182741
15.
Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism.
Psychopharmacology (Berl)
; 214(4): 843-53, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21088957
16.
Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia.
Psychopharmacology (Berl)
; 214(2): 403-13, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20957350
17.
Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
Eur Neuropsychopharmacol
; 21(4): 333-43, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20630711
18.
Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats.
Behav Brain Res
; 207(1): 144-50, 2010 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-19822174
19.
Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
Behav Brain Res
; 214(2): 240-7, 2010 Dec 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-20561963
20.
Comparison of the efficacy of two anticonvulsants, phenytoin and valproate to improve PCP and d-amphetamine induced deficits in a reversal learning task in the rat.
Front Behav Neurosci
; 3: 8, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19562089